W. Golusinski
Papers
1
Total Citations
2
H-Index
1
About
W. Golusinski is a leading figure in head and neck surgical oncology, with a primary research focus on optimizing treatment strategies for oropharyngeal, supraglottic, and hypopharyngeal carcinomas. His major contribution lies in pioneering comparative effectiveness research between surgical and radiotherapeutic approaches for early-stage disease. Notably, his work on the Phase III study (2022) directly addresses a critical clinical dilemma: whether trans-oral surgery (TOS) or radiotherapy yields superior oncologic and functional outcomes for patients with T1-T2, N0-N1 tumors. This trial, though recently published with 2 citations, represents a landmark effort to establish evidence-based guidelines in a field historically dominated by institutional preference. Golusinski’s impact extends beyond individual studies; he has been instrumental in shaping multidisciplinary treatment paradigms, emphasizing the importance of personalized, organ-preserving therapies. His research continues to influence clinical decision-making, offering patients and surgeons clearer data on the trade-offs between surgical resection and radiation. For students and researchers, Golusinski’s work exemplifies how rigorous comparative trials can resolve long-standing controversies in head and neck cancer management.
Research Focus
Key Achievements
Top Papers
- 1